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Abstract Using ultrastructural analysis and labeling with
polyclonal antibodies that recognize peptide sequences specific
for phospholipid binding, we mapped the functional domain
structure of intact platelet talin and its proteolytic fragments.
The talin dimer, which is crucial for actin and lipid binding, is
built of a backbone containing the 200 kDa rod portions, at both
ends of which a 47 kDa globular domain is attached. Peptide-
specific polyclonal antibodies were raised against three potential
lipid binding sequences residing within the N-terminal 47 kDa
domain (i.e. S19, amino acids 21^39; H18, amino acids 287^
304; and H17, amino acids 385^406). Antibodies H17 and H18
localize these lipid binding sequences within the N-terminal 47
kDa globular talin subdomains opposed at the outer 200 kDa rod
domains within talin dimers. Hence, we conclude that in its
dimeric form, which is used in actin and lipid binding, talin is a
dumbbell-shaped molecule built of two antiparallel subunits.
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1. Introduction
Talin is a highly conserved, widespread protein, ¢rst iden-
ti¢ed as a major protein in focal cell adhesions [1] and sub-
sequently found also in the leading edge of moving cells [2].
Its striking co-localization with nascent actin ¢lament net-
works and bundles which are formed during cell protrusion
prompted us to investigate the binding of talin to actin [3].
Using stopped-£ow kinetics, we showed that talin binds G-
actin with a Kd of 0.3U1036 M and at a rate of 7U106 M31
s31, and dissociates 2^3 molecules per second. Independently,
Muguruma et al. [4] used gel ¢ltration to demonstrate the
binding of talin to actin. When analyzing actin polymerization
in the presence of talin at pH 8.0 and various ionic conditions,
we found that talin promotes actin ¢lament nucleation by a
factor of around 2.5 regardless of whether actin-ATP [5,6] or
actin-ADP [7] is used. Moreover, it is known that talin at pH
6.4 and low ionic strength acts as a crosslinking and bundling
protein, linking individual actin ¢laments into three-dimen-
sional networks [8^10]. Based on its primary sequence, three
potential actin binding regions have been mapped along the
talin sequence [11,12], the C-terminal and the N-terminal re-
gions being the most conserved [11]. Which of the three sites
contributes to the various functions of actin binding has not
yet been determined. However, although we have been unable
to demonstrate any functional actin binding activity in the N-
terminal 47 kDa head portion of the talin molecule, we do
know that the actin nucleating and actin crosslinking activities
remain intact in the 200 kDa C-terminal tail fragment [10,13].
The partial extraction of talin from membrane preparations
prompted our investigation of its lipid binding capacity. A
combination of biochemical and biophysical techniques en-
abled us to reliably document a stable interaction of talin
with phospholipid membranes. For example, using di¡erential
scanning calorimetry (DSC) we were able to discriminate elec-
trostatic adsorption from hydrophobic insertion during the
interaction of intact talin with lipid vesicles [14]. The hydro-
phobic insertion into at least one half of the hydrophobic lipid
bilayer was con¢rmed by the application of photoactivatable
lipid analogues (hydrophobic lipid photolabeling), which se-
lectively react with protein domains only when inserted into
the hydrophobic part of lipid membranes [6]. Moreover, the
binding of talin to lipid surfaces is greatly enhanced in the
presence of negatively charged phospholipids. This was dem-
onstrated for DMPC/DMPG lipid mixtures using FTIR with
one partner deuterated (DMPC-d54) [14], and for mixed
DPPC/DMPG monolayers where talin was observed to segre-
gate into regions rich in negatively charged phospholipids [15].
The molar a⁄nity of talin to lipids (Kd V0.3 WM) resembles
that of moderate protein-protein interactions [16].
Given the apparent sequence homology (s 40%) with the
membrane and actin binding proteins 4.1 and ezrin [17], it has
been speculated that the lipid binding domain resides in the
smaller 47 kDa calpain II cleavage product [18]. Indeed, we
have con¢rmed by a combination of functional and analytical
assays that the 47 kDa head portion harbors an exposed lipid
binding domain [13]. Though the 200 kDa talin rod domain
exhibits a repetitive hydrophobic core pattern consisting of
repeated motifs of amphiphilic K-helices [19], it seems unlikely
that further lipid binding domains are exposed on the rod
portion, since out of a mixture of 47 kDa and 200 kDa frag-
ments only the 47 kDa domain bound to lipid vesicles [13].
There is evidence that puri¢ed talin exists in an equilibrium
between monomers and dimers [20]. The dimer con¢guration,
which is functional during actin interaction, is represented
ultrastructurally by a dumbbell-shaped homodimer, 51 nm
in length and with an antiparallel arrangement of its two
monomers [21]. Whereas quantitative dimerization of talin
[21] has been con¢rmed by employing the zero-length cross-
linker EDC [22], there is still controversy over the antiparallel
[21] or parallel [22] arrangement of subunits within the dimer.
By determining that the two functionally di¡erent domains,
the 47 kDa membrane binding domain and the actin binding
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rod portion, can be ultrastructurally attributed to distinct re-
gions of the talin homodimer, we provide strong evidence in
favor of an antiparallel orientation of talin subunits.
Using data gathered by electron microscopic analysis of the
thrombin cleavage products of talin and the application of
monospeci¢c a⁄nity puri¢ed polyclonal antibodies raised
against synthetic peptides which by computer-assisted struc-
ture predictions have been designated to carry the three most
likely lipid binding motifs within the 47 kDa talin subfrag-
ment [23], we here present the ¢rst structural evidence for the
functional domain arrangement within the talin homodimer.
Based on this structural domain organization of the function-
al talin molecule, we present a model of the orientation of
talin within the lipid plasma membrane.
Taken together, our data are in line with the concept that
talin is a key molecule for anchoring actin ¢laments to the
lipid membrane at cell/matrix junctions and for nucleating
actin assembly at the membrane interface of leading edges
[24]. For the gradual evolution of this concept, see [25^28].
2. Materials and methods
2.1. Proteins
Talin was puri¢ed from outdated human platelets to homogeneity
as judged by SDS-PAGE (cf. Fig. 1) [5], and the protein concentra-
tions were determined as described by Bradford [29]. Puri¢ed talin in
bu¡er B (50 mM Tris-HCl pH 8; 0.3 mM EDTA, 0.1 mM DTT) was
digested by thrombin (0.5 U/mg protein) at room temperature. After
40 min of digestion, benzamidine (¢nal concentration 10 mM) was
added, and the cleavage products were separated on an FPLC anion
exchange column (Mono Q, Pharmacia Fine Chemicals) with a linear
gradient of 0^800 mM NaCl in bu¡er B. The 47 kDa fragment is
recovered from the £ow-through, whereas the 200 kDa domain elutes
at 500 mM NaCl.
2.2. Synthetic peptides
The following three peptides, with the highest lipid binding proba-
bility according to computer-assisted structure predictions [23], were
synthesized on the basis of the mouse talin sequence: residues 21^39:
PSTMVYDACRMIRERIPEA (S19; MW 2236.66); residues 287^
304: GQMSEIEAKVRYVKLARS (H18; MW 2064.46); residues
385^406: GEQIAQLIAGYIDIILKKKKSK (H17; MW 2457.02).
All peptides were veri¢ed by mass spectroscopy; the purity was
s 80%. For immunization, 2 mg of peptide was coupled to 2 mg of
keyhole limpet hemocyanin (KLH) as carrier. The conjugate was sep-
arated on a Sephadex G-25 column and stored in PBS at 4 mg/ml.
2.3. Peptide-speci¢c antibodies
New Zealand white rabbits (2.0^2.5 kg) were immunized with 300
Wg immunogen each in 300 Wl PBS and 1 ml adjuvant sequentially into
lymph nodes, intramuscular and subcutaneously. Monospeci¢c IgGs
were isolated from 10 ml serum on a CNBr-Sepharose a⁄nity column
to which 2^3 mg of the speci¢c peptide had been coupled.
2.4. Electron microscopy
For glycerol spraying/low-angle rotary metal shadowing, we proc-
essed protein samples as described in detail previously [21]. Brie£y,
0.1^0.3 mg/ml talin in 30% glycerol was sprayed onto freshly cleaved
mica, dried under vacuum at room temperature for 1 h and rotary
metal-shadowed at an elevation angle of 3^5‡ with platinum/carbon.
For antibody labeling, an aliquot of talin was incubated for 90 min at
room temperature with various amounts of the a⁄nity puri¢ed IgG
up to a 1:1 molar ratio. Specimens were viewed in a Hitachi H-8000
transmission electron microscopy (TEM) operated at 100 kV. Electron
micrographs were recorded on Kodak SO-163 electron image ¢lm at a
nominal magni¢cation of U50 000.
3. Results
3.1. Morphology of intact talin and its proteolytic fragments
Thrombin cleavage of talin yields two fragments of 200
kDa and 47 kDa, respectively (Fig. 1). These subunits repre-
sent the N-terminal membrane binding head portion (47 kDa)
and the actin interacting C-terminal rod domain [13]. Fig. 2
reveals the corresponding electron micrographs of the total
native talin molecule and the puri¢ed fragments. Consistent
with previous documentation, here native talin appears as a
dumbbell-shaped elongated molecule with a condensed glob-
ular structure at opposite ends of the homodimer (Fig. 2a).
When viewing the puri¢ed 200 kDa rod domain (Fig. 2b)
these protein portions appear as elongated structures with
dimensions comparable to the native protein (51 nm) but
with a statistically signi¢cant loss of the two globular end
domains. Likewise, when viewing the puri¢ed 47 kDa subdo-
main (Fig. 1, lane 4), the globular structures, which in density
and size compare well with the oppositely arranged condensed
regions in the intact molecule, are the only visible structures in
these preparations (Fig. 2c).
3.2. Labeling intact talin with peptide-speci¢c antibodies
All three sequence stretches which have been predicted to
contain potential lipid binding sites [23] reside in the 47 kDa
head portion of the talin molecule. In a parallel study, it has
been con¢rmed (by calorimetry, monolayer studies and CD
spectroscopy) that indeed the synthetic talin peptides interact
with lipid membranes, with a strong preference for peptide
H17, residues 385^406 (GEQIAQLIAGYIDIILKKKKSK),
as has been assessed by computer-based structure predictions,
when taking into account hydrophobic moments, surface-
seeking structure formation and K-helix formation (data not
shown).
Labeling of native talin molecules with monospeci¢c IgGs
which were raised against synthetic peptides and puri¢ed on
peptide a⁄nity columns is shown in Fig. 3. The unlabeled
talin molecule is displayed in Fig. 3a and the antibody alone
is shown in Fig. 3b. Incubation of native talin molecules with
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Fig. 1. SDS-PAGE of human platelet talin and its proteolytic frag-
ments. 3 Wg of protein was loaded per lane. Intact talin (lane 2); C-
terminal 200 kDa rod fragment (lane 3); and 47 kDa N-terminal
head fragment (lane 4). For calibration, MW standards have been
included as indicated (lane 1). Corresponding samples were viewed
by transmission electron microscopy after glycerol spraying/low-an-
gle rotary metal shadowing (cf. Fig. 2).
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antibodies directed against lipid binding sequences within the
47 kDa talin head domain results in labeling as shown in Fig.
3c^f. As documented, we observed exclusive labeling of the
globular, oppositely arranged protein domains. When we used
a 1:1 molar ratio of antibody to talin, we observed a high
background of unbound antibody, indicating a relatively low
binding a⁄nity of the antibody for talin. Binding is most
commonly observed on either end of the talin homodimer.
However, labeling occurred convincingly on both opposite
ends simultaneously (Fig. 3e,f). Alternatively, talin molecules
were crosslinked by antibodies via their globular end domains.
Peptide-speci¢c antibodies raised against H17 and H18 both
resulted in a similar labeling, whereas labeling with antibodies
directed against peptide S19, carrying the very N-terminal
amino acid sequence 21^39, was unsuccessful.
4. Discussion
By combining ultrastructural analysis of intact talin and the
47 kDa as well as the 200 kDa proteolytic fragments of talin
and peptide-speci¢c antibody labeling, we were able to map
the domain structure of individual talin molecules. Talin is
bifunctional in that it can bind to actin via its 200 kDa C-
terminal rod portion and simultaneously can anchor to the
plasma membrane by its 47 kDa N-terminal head domain
by speci¢cally interacting with phospholipids [5,6,13,24,
26,28,30]. So far, it has remained elusive where on the talin
molecule these two functional domains reside. It was also of
interest to determine how talin might be oriented with respect
to the lipid interface and which domain of the talin molecule
might be responsible for inserting into the lipid bilayer. As
judged by SDS-PAGE, talin is quantitatively cleaved by
thrombin into its N-terminal 47 kDa membrane binding do-
main and its C-terminal 200 kDa rod portion harboring pri-
marily actin binding sites [11^13] but also the integrin [31] and
vinculin [32] binding sites.
In agreement with our previously published experimental
data [21], we regard the dimer to be the functional con¢gu-
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Fig. 2. Ultrastructure of intact talin and its proteolytic fragments as viewed after glycerol spraying, low-angle rotary metal shadowing. a: Intact
talin. b: The 200 kDa C-terminal rod fragment. c: The 47 kDa globular N-terminal head fragment. Scale bar, 100 nm (a^c).
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ration for actin binding. Dimer formation occurs within the
200 kDa C-terminal tail fragments but not within the 47 kDa
N-terminal domains [22]. Even GST fusion proteins contain-
ing the highly conserved C-terminal actin binding module I/
LWEQ migrate exclusively as dimers on gel ¢ltration columns
under physiological ionic conditions [33]. We have experimen-
tal evidence [10] that the 200 kDa C-terminal domains alone
are su⁄cient to crosslink actin ¢laments into a three-dimen-
sional network. Since the most e¡ective actin binding sites are
located at the C-terminal end of the talin rod domain [12,33],
it is inconceivable how an actin ¢lament could e¡ectively
crosslink into a gel, if talin were a parallel dimer.
Convincing evidence that talin forms antiparallel dimers is
found in labeling the 47 kDa membrane binding domain with
polyclonal antibodies that have been raised against synthetic
peptides representing lipid binding sequences within the 47
kDa N-terminal membrane binding domain. In no case did
these antibodies bind to the rod domain. Instead, the anti-
bodies bound to the globular end domains of the dumbbell-
shaped talin molecules. Moreover, in no case did we observe
two antibodies binding to one and the same globular end
domain of the dumbbell-shaped talin molecule. On the other
hand, several instances occurred where both globular end do-
mains of the dumbbell-shaped talin molecule were decorated
with an antibody. Hence, our data do not support the view of
Winkler et al. [22] that talin dimers, according to their energy-
¢ltered electron micrographs, may be arranged in a parallel
con¢guration.
Following our model (Fig. 4), one would further anticipate
that talin is anchored in lipid membranes at two sites via its
two globular 47 kDa end domains. The rod domain facing the
cytoplasm would then allow interaction with actin ¢laments
either by nucleating assembly [5,30] or by crosslinking actin
¢laments [9,10]. Whether the two actin binding domains with-
in the rod are responsible for the two di¡erent functions re-
mains elusive. Since talin has no capping activity, the physical
ends of actin ¢laments would be accessible for the addition of
actin monomers. Moreover, in cells the free ends of actin
¢laments impinge on the membrane with certain average an-
gles. The angle under which protrusion by polymerization
would be maximal has been calculated to be Q = 48‡ [34],
which is close to the angle found in situ. We have observed
that talin clearly exhibits a £exible hinge region in the middle
of the antiparallel, dimeric molecule, thereby allowing for
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Fig. 3. Labeling of lipid binding sequences within the 47 kDa N-terminal globular head domain by polyclonal peptide-speci¢c antibodies. a: In-
tact talin molecules. b: A⁄nity-puri¢ed IgG (H18) used for labeling experiments in c^f. Note the di¡erence in size as compared to the 47 kDa
globular talin head domain under identical magni¢cation (c^f). Localization of lipid binding epitopes to the 47 kDa globular end of talin
dimers, or to both oppositely arranged globular 47 kDa domains simultaneously (f), indicating an antiparallel arrangement of talin within its
dimer con¢guration. Scale bar, 100 nm (a^f).
G. Isenberg, W.H. Goldmann/FEBS Letters 426 (1998) 165^170168
various kink positions. Assuming that the lipid binding do-
mains, i.e. the 47 kDa N-terminal end domains are freely
di¡usible within the plane of the membrane, one would ac-
cording to this hypothetical model predict that the crosslink-
ing angle of the adjacent actin ¢lament lattice correlates with
the di¡usion coe⁄cient of the talin lipid binding domains, i.e.
when di¡usion is restricted due to the assembly of associated
proteins, e.g. vinculin and integrins as in focal contacts, the
actin ¢lament lattice will be dense resulting ideally in strongly
oriented ¢lament cables; when the di¡usion rate is enhanced,
as in advancing lamellipodium membranes [35], this would
result in loose network formation (cf. the hypothetical model
in Fig. 4).
Several in vivo observations already support the concept
that talin is intimately involved not only in cytoskeleton/mem-
brane anchoring but also in motility regulation. Polyclonal
antibodies to talin were found to inhibit cell migration and
adhesion on ¢bronectin when microinjected into ¢broblasts
[36]. HeLa cells, when down-regulated in talin expression by
antisense RNA, also exhibited a reduced rate in cell spreading
[37]. More recently, Niewoºhner et al. [38] using a talin ‘knock-
out’ strain in Dictyostelium discoideum produced a drastically
altered phenotype impaired in adhesion and phagocytosis,
which is consistent with the importance of talin for the mo-
tility behavior of these cells. Finally, microinjection of an anti-
body (TA 205) that recognizes the N-terminal epitope AA
139^433 in the talin sequence inhibits motility and disrupts
stress ¢bers when injected into chicken embryo ¢broblasts
[12]. Interestingly, this large sequence region harbors an actin
binding domain [11], but it also covers the lipid binding do-
main AA 385^406, which we have structurally mapped as
demonstrated in this report using a peptide antibody directed
against this functional site.
The next conceivable step would therefore be to determine
the e¡ect of the microinjection of antibodies that recognize
lipid binding epitopes on cell motility and cytoskeleton archi-
tecture, inasmuch as it has not yet been possible to discrim-
inate whether the talin antibody TA 205 interfered with an
actin or with a lipid binding epitope.
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